InsidersTradesSigma
BioGaia AB: management transactions · Finland · FIN-FSA
FI:biogaia-ab-26700dSE0017769995FI·FIN-FSAMcap 13.2Bn€Healthcare
Browse the full insider trade history of BioGaia AB, a publicly traded company based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, BioGaia AB has logged 6 insider filings. Market capitalisation: €13.2bn. The latest transaction was filed on 13 August 2025 — Purchase. Among the most active insiders: Theresa Puleo Agnew. The full history is free.
6
Insider Decl.
0
Thresholds
€34,674
4 ops.
Buy Volume
€17m
2 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
130.00 €
Analyst consensus
1 analystsStrong buy
165.00 €Target 165.00 €(+27%)165.00 €
Income statement
Revenue1.54 Bn€
Gross profit1.13 Bn€73% margin
Net income332.8 M€21.5% margin
Valuation
PER (trailing)39.6x
PER (forward)26.1x
P/Book9.4x
Balance sheet & cash
Market cap13.15 Bn€
Total debt10.4 M€
Free Cash Flow303.0 M€
Profitability & ownership
ROE20.9%
ROA15.3%
% insiders16.1%
% institutions60.4%
Last declaration on 13 August 2025
Declarations6 total
Executives●Purchase35FIN-FSA
€14,9221,767 shares@ €8.4450.0001% mcap100.0% of flow
Aktie
FI:A003R373-1·
Ideal exit: 8 May 2026 (T+270)
Executives●Sale26FIN-FSA
€12m1,038,202 shares@ €11.89130.094% mcap100.0% of flow
Aktie
FI:A003O682-1·
Executives●Purchase16FIN-FSA
€1,336136 shares@ €9.82280.0000% mcap6.8% of flow
Aktie
FI:A003O451-1·
Ideal exit: 10 Feb 2026 (T+270)
Executives●Sale24FIN-FSA
€5m500,000 shares@ €9.87960.038% mcap100.0% of flow
Aktie
FI:A003O299-1·
Executives●Purchase20FIN-FSA
€18,4162,015 shares@ €9.13930.0001% mcap93.2% of flow
Aktie
FI:A003O021-1·
Ideal exit: 2 Feb 2026 (T+270)
Executives●Purchase27FIN-FSA
060,000 shares0
Option
FI:A003M373-1·
Ideal exit: 5 Dec 2025 (T+270)
6 of 6 declarations